Back in March, the Food and Drug Administration approved an epilepsy pill known as SPRITAM, representing the first FDA approved 3D-printed drug. Through the use of additive manufacturing, the drug’s creator was able to give the pill a new structure and coating that allows it to dissolve more quickly for superior performance.
Recognizing the value of 3D printing in the medical field is a big step forward for the FDA. Unfortunately, the technology comes with its own set of challenges that the department needs to account for. According to new regulations imposed by the FDA, all component materials must be listed in the production of printed medical supplies, along with the way that these components are layered. These guidelines may be somewhat demanding for certain manufacturers, but they still represent a promising outlook for the future of printable pharmaceuticals.
Indeed, 3D printing technology has limitless potential in a wide variety of fields. Talk to our Seattle 3D printing company to learn more about what we can do to bring your own dreams to fruition.
